Professor Rosier holds both a Doctorate in Pharmaceutical Sciences (Ghent University, Belgium) and a Doctorate in Management (Cranfield School of Management, UK). He was a Fulbright Scholar at Harvard University and was awarded a NATO research fellowship for research at MIT, Cambridge.
Since 2008, he teaches new drug development at the University of Leuven at Trinity College Dublin as a visiting professor. Jan is author of 'Global New Drug Development’ (Wiley-Blackwell) and ‘The High Tech CEO’ (Routledge). He is a member of the Advisory Board of Incentives for Global Health's Health Impact Fund ((opens in a new window)healthimpactfund.org).